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Abstract 21 
Herein, for the first time, we combined poly-L-Lactic acid (PLLA) with a strontium 22 
borosilicate bioactive glass (BBG-Sr) using electrospinning to fabricate a composite 23 
bioactive PLLA membrane loaded with 10 % (w/w) of BBG-Sr glass particles (PLLA-24 
BBG-Sr). The composites were characterised by scanning electron microscopy (SEM) 25 
DQG PLFURFRPSXWHU WRPRJUDSK\ ȝ-CT), and the results showed that we successfully 26 
fabricated smooth and uniform fibres (1 to 3 µm in width) with a homogeneous 27 
distribution of BBG-Sr microparticles (< 45µm). Degradation studies (in phosphate 28 
buffered saline) demonstrated that the incorporation of BBG-Sr glass particles into the 29 
PLLA membranes increased their degradability and water uptake with a continuous 30 
release of cations. The addition of BBG-Sr glass particles enhanced the memEUDQH¶V 31 
mechanical properties (69 % higher Young modulus and 36 % higher tensile strength). 32 
Furthermore, cellular in vitro evaluation using bone marrow-derived mesenchymal stem 33 
cells (BM-MSCs) demonstrated that PLLA-BBG-Sr membranes promoted the 34 
osteogenic differentiation of the cells as demonstrated by increased alkaline phosphatase 35 
activity and up-regulated osteogenic gene expression (Alpl, Sp7 and Bglap) in relation 36 
to PLLA alone. These results strongly suggest that the composite PLLA membranes 37 
reinforced with the BBG-Sr glass particles have potential  as an effective biomaterial 38 
capable of promoting bone regeneration. 39 
 40 
Key words: Strontium borosilicate glasses, PLLA membranes, mineralisation, 41 
osteogenic differentiation, BM-MSCs 42 
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1. Introduction 44 
The development of biomaterials for guided bone tissue engineering (BTE) has been a 45 
hot topic of research in recent years. Biomaterials can act as a short-term template in 46 
which cells proliferate and deposit extracellular matrix (ECM), helping bone ingrowth 47 
as a part of its regeneration process. A suitable biomaterial for BTE should present 48 
appropriate mechanical properties that is able to withstand the mechanical stress 49 
occurring at the lesion site and to support cell ingrowth as part of the bone formation 50 
process. The capacity to shape the biomaterial substrate to fit exactly in the bone lesion 51 
is of particular relevance, too [1, 2]. 52 
Electrospinning is a versatile technique that applies electrostatic forces to manufacture 53 
ultrathin fibre meshes from melted polymers or polymer solutions. This methodology 54 
has been used to obtain biomaterials composed by micro- or nano-fibres with high 55 
surface areas and mechanical properties suitable for BTE by playing with its different 56 
processing parameters [2, 3]. Furthermore, electrospun membranes closely mimic the 57 
ECM promoting cell attachment and proliferation [4]. 58 
Poly-L-lactic acid (PLLA) is a biodegradable and biocompatible polymer, widely 59 
investigated for BTE, specially due to the approval of different PLLA medical devices 60 
for clinical use by the US Federal Food and Drug Administration (FDA) [5]. 61 
Furthermore, PLLA has appropriate flexibility and deformation capacity, and can be 62 
processed by different techniques (e.g. melt, dry and wet spinning, as well as 63 
electrospinning) [6-9]. However, PLLA is not commonly considered osteoinductive [4, 64 
10]. Thus, in order to improve the biological performance of PLLA fibres, the 65 
polymeric matrix can be combined with inorganic materials, such as bioactive glasses 66 
(BG) and glass-ceramics, improving its osteoinductive potential [11, 12]. Moreover, the 67 
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PLLA degradation rate can be shaped by several different variables (e.g. chemical 68 
structure and crystallinity of the polymer, size and shape of the final material), although, 69 
the matching of the rate of degradation and the kinetics of the formation of new bone 70 
tissue is still difficult to achieve [13, 14]. The addition of an inorganic phase allows a 71 
better control of the degradation rate of the final PLLA-glass composite, which can be 72 
used to manufacture a composite with a suitable degradation rate while progressively 73 
being substituted by the new bone that is being formed [15]. 74 
Bioactive glasses (BGs) are a group of inorganic bioactive materials that are able to 75 
form a bone-like hydroxyapatite (HA) layer on their surface capable to strongly bond to 76 
hard and soft tissues [11, 16-18]. Immediately after the launch of the 45S5 Bioglass® in 77 
the market (chemical composition by mol: 0.45SiO2  0.06P2O5  0.245Na2O  78 
0.245CaO) it became the gold standard for bioactive glass materials [16]. Subsequently, 79 
a wide range of BGs based on the 45S5 composition have been developed and studied 80 
for BTE [19, 20]. The addition of borate glass forming units is one approach that has 81 
potential to lower melting temperatures while controlling bio-degradation and 82 
increasing conversion rates to HA [21, 22]. Borosilicate-based BGs (BBGs) have 83 
previously been studied as biomaterials and have shown relevant capacity as 84 
osteointegrative antibacterial materials to be used in BTE [23, 24]. BBGs have been 85 
also incorporated into scaffolds: Wang et al. [25] successfully incorporated copper 86 
doped borosilicate glasses (BBG-Cu) into a polymeric scaffold for tissue engineering 87 
purposes. They observed an improvement in the stability of the glass network and the 88 
BBG-Cu promoted the angiogenesis in rat calvarial defects. 89 
Moreover, in our previous studies we tested a BBG glass composition (e.g. molar ratio: 90 
BBG-Sr: 0.05Na2O  0.35SrO  0.20B2O3  0.40SiO2) for their osteogenic capacity. We 91 
found that the presence of BBG-Sr glass particles improved the osteogenic 92 
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differentiation of bone marrow mesenchymal stem cells (BM-MSCs) and induced also 93 
the formation of mineralised tissue. We also demonstrated that demonstrated that BBG-94 
6U DW FRQFHQWUDWLRQV   PJP/ LW ZDV DEOH WR HUDGLFDWH Pseudomonas aeruginosa 95 
bacterium [26]. Numerous reports have already associated Sr2+ with bone therapeutic 96 
potential [19]. Depending on the concentration Sr2+ can exerts many effects on bone 97 
metabolism at the tissue and cellular levels as well as in bone formation in vivo [27, 28]. 98 
For instance, Marie et al. [27] demonstrated strontium modulates bone cell function 99 
(e.g. cell proliferation and differentiation)  in vitro stimulating bone formation and 100 
inhibiting bone resorption. Moreover, Hesaraki et al. showed that glasses doped with 101 
Strontium promoted osteoblast proliferation and ALP activity when directly in culture 102 
with cells [29]. For instance, Wu et al. [30] developed a strontium silicate glass which 103 
promoted a high ALP activity in BM-MSC cell culture, which was associated with the 104 
release of Sr2+ and silica. Also, Santocildes-Romero et al. [31] demonstrated that 105 
strontium-substituted bioactive glasses promoted osteogenic differentiation of BM-106 
MSCs cultures in the presence of strontium -containing BGs. They showed an increased 107 
expression of genes such as Alpl and Bglap. Moreover, Gentleman et al. [32] studied the 108 
effect of the release of Si- and Sr-related chemical entities from PCL-SrBG scaffolds, 109 
and they detected that the SrBG particles stimulated osteoblast proliferation and ALP 110 
activity in relation to the SrBG-free PCL scaffold. Moreover, BM-MSCs are of special 111 
interest due to their capacity to differentiation into different lineages (including 112 
osteoblastic cells) with appropriate external stimuli and the fact that it is relatively easy 113 
to isolate [33]. For that reason, BM-MSCs have received extensive attention as 114 
promoters of tissue regeneration. 115 
To our knowledge, the PLLA-BBG-Sr composite membranes fabricated by 116 
electrospinning has not been achieved to-date. Therefore, we aimed to evaluate the 117 
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potential of PLLA-BBG-Sr composite membranes for BTE and bone regeneration. 118 
Herein, we investigated the impact of the incorporation of BBG-Sr glass particles in 119 
PLLA fibre meshes on their tensile strength and degradation. Moreover, we evaluated 120 
the response of BM-MSCs in the presence of PLLA-BBG-Sr fibres, namely in what 121 
regards their morphology, proliferation and ability to induce its differentiation. 122 
2. Experimental 123 
2.1. Materials 124 
All chemicals used for the melt-quenched synthesis were reagent grade: boron oxide 125 
(B2O3, Alfa Aesar, Germany), calcium carbonate (CaCO3, Sigma-Aldrich, UK), sodium 126 
bicarbonate (NaHCO3, Sigma-Aldrich, Australia), silica gel 60M (SiO2, Macherey-127 
Nagel, Germany), magnesium oxide (MgO, Sigma-Aldrich, UK) and strontium 128 
carbonate (SrCO3, Sigma-Aldrich, Australia). All the chemical reagents used for 129 
electrospinning were reagent grade: PLLA with a L-lactide content of 99.6 % and an 130 
average Mw of 69,000 g.mol-1 (Cargill Dow LLC, USA), dichloromethane (Sigma-131 
Aldrich, UK), and the anionic surfactant docusate sodium salt (Sigma-Aldrich, UK). 132 
The BBGs were produced as described elsewhere. Briefly, the appropriate amounts of 133 
SiO2, B2O3, NaHCO3, and CaCO3 or MgO or SrCO3, were accurately mixed with 134 
ethanol (Sigma, Portugal) in a porcelain pestle and mortar, fully dried overnight and 135 
transfer to a platinum crucible (ZGS platinum, Johnson Matthey, UK). Each batch (~ 50 136 
g) was heated to 1450 ºC in air for 1 hour and, subsequently, the melt was quickly 137 
poured into an ice-water bath at ~ 0 Û&WRIRUPDJODVVIULW$IWHUZDUGV the glasses of 138 
general formula 0.05Na2O  xMgO  yCaO  (0.35-x-y)SrO  0.20B2O3  0.40SiO2 (molar 139 
ratio, where x, y = 0.35 or 0.00, and x y) were ground into an Agate mortar (RETSCH, 140 
Germany) to obtain microparticles and sieved to a size <ȝP to be homogeneously 141 
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incorporated in the polymeric matrix during the fabrication of the fibres. The density of 142 
the BBGs was measured by a Multi pycnometer (Quantachrome Instruments, USA) 143 
under helium at 110 °C using ~ 5 g of each sample. 144 
2.2. Glasses synthesis and membranes preparation 145 
Electrospinning. PLLA-BBG-Sr membranes were fabricated inside a fume hood 146 
cabinet for safe solvent evaporation and in order to prevent that the turbulent air 147 
interferes in the formation of the fibres. The PLLA concentration, the ratio of PLLA/ 148 
BBG-Sr and the process parameters (e.g. applied voltage, flow rate and distance from 149 
the collector) were optimized in order to obtain uniform membrane of fibres. The final 150 
electrospun membranes were fabricated using PLLA dissolved in dichloromethane (16 151 
% w/v) where the BBGs microparticles were suspended (10 % w/w BBGs/PLLA). 152 
Docusate sodium salt (1.2 % w/w relative to PLLA) was used to help the 153 
homogenization of the solution avoiding the formation of agglomerates. The PLLA and 154 
PLLA-BBG-Sr solutions were stirred overnight and sonicated 5 min before use to 155 
remove air bubbles. The set up was mounted using a high voltage supplier, a syringe 156 
pump (Baxter AS50) with a 20 gauge metal needle (Fisnar, New Jersey, USA) and a 157 
conductive collector. The PLLA and PLLA-BBG-Sr solutions were drawn up into a 1 158 
ml syringe (BD Plastipak, New Jersey, USA). The solutions were electrospun using 17 159 
kV and a flow rate of 3 mL/h at a 19 cm distance between the collector and needle. The 160 
electrospun membranes were dried in a fume hood, at room temperature, for 24 h, 161 
collected and stored in a desiccator at room temperature. 162 
2.3. Characterisation of electro-spun membranes 163 
2.3.1. Scanning electron microscopy (SEM) 164 
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The Scanning Electron Microscopy (Leica Cambridge S360 microscope, equipped with 165 
an energy dispersive spectrometer, UK) was used to assess the surface morphology of 166 
the fabricated PLLA and PLLA-BBG-Sr membranes. Prior to the analysis, all the 167 
scaffolds were sputter-coated with gold. The micrographs were acquired using a beam 168 
energy of 5.0kV and working distance (WD) of ~ 5.2 mm. 169 
2.3.2. Micro-computed tomography (µCT) 170 
Micro-computed tomography (µ-CT) was carried out on a high-resolution µ-CT scanner 171 
(SkyScan1272, Bruker, Kontich, Belgium), using a pixel size of 9.8 µm and integration 172 
time of 160 ms. The X-ray source was set at 50 kV of energy and 200 µA of current. 173 
Approximately 400 projections were acquired over a rotation range of 180° with a 174 
rotation step of 0.60°. Data sets were reconstructed using standardised cone-beam 175 
reconstruction software (NRecon v1.6.10.2, SkyScan). The output format for each 176 
sample was a series of 601 bitmap images (1224 × 1224 pixels). 3D virtual models of 177 
representative regions in the bulk of the scaffolds were created applying colour channel 178 
thresholds and visualised using an image processing software (CTvox). 179 
2.3.3. Mechanical tests 180 
Tensile strength and modulus of the PLLA and PLLA-BBG-Sr membranes were 181 
measured using a Uniaxial Universal Testing Machine (Instron 4505, USA) according 182 
to the standard ASTM D 638. The membranes were cut into strips of 50 mm length, 10 183 
mm width and 0.1 mm thickness. The tests were conducted using a 1 kN load cell, with 184 
a gauge length of 20 mm and a crosshead speed of 5 mm.min-1 until rupture. The tensile 185 
force was taken from the stress-strain curves as the maximum stress hold by the 186 
samples. Tensile modulus was estimated from the initial slope of the stress±strain curve 187 
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(between 0.5 % and 1 % strain) using the linear regression method. The average and 188 
standard deviations were determined using 5 specimens per composition. 189 
2.3.4. Degradation assay 190 
The electrospun membranes (n= 3 per time point) were immersed in PBS (Sigma-191 
Aldrich, UK) at a ratio of 10:10 (membrane (mg): PBS (mL)) for 7, 14, 21, and 28 days 192 
in a water-shaking bath at 60 rpm and 37 &(DFKLPPHUVLRQVROXWLRQZDV¿OWHUHGDQG193 
the pH measured (Crison Instruments, Spain). Inductive coupled plasma (ICP) analysis 194 
was performed to determine the concentrations of Si, B and Sr in solution. The 195 
DEVRUSWLRQZDVPHDVXUHDWVSHFLILFZDYHOHQJWKVȜ QPIRU6LȜ QP196 
for B and Ȝ   QP IRU 6U DQG WKH FRQFHQWUDWLRQV ZHUH GHWHUPLQHG XVLQJ197 
calibration curves obtained with standard solutions (Alfa Aesar) prior to the analysis of 198 
the samples. 199 
The membranes were removed from PBS, the excess surface water was removed and 200 
the samples were immediately weighed. Afterwards, the samples were dried in the oven 201 
at 37 °C, to constant weight, recording the final mass of the membranes. The water 202 
uptake (WU) was calculated according to Eq. (1): 203 
ܹܷሺ ?ሻ ൌ ሺ݉௧௣ െ ݉௙ሻ ݉௙ ? ൈ  ? ? ?   Eq. (1) 204 
Where mtp is the wet mass of the specimen at the specific time (days), and mf is the final 205 
mass after immersion and drying. The weight loss (WL) was calculated according to Eq. 206 
(2): 207 
ܹܮሺ ?ሻ ൌ ሺ݉௙ െ ݉௜ሻ ݉௜ ? ൈ  ? ? ?    Eq. (2) 208 
Where mf is the mass of the dried membranes after its immersion in water, and mi is the 209 
mass of the dried membranes before immersion in PBS. 210 
9 
 
 9 
Thermogravimetric analysis (TGA; Q500, TA Instruments, USA) was also used to 211 
quantify the changes in the weight (mass) of the membranes during the degradation 212 
process. In addition, thermal analysis was performed to determine the amount of BBG-213 
Sr (non-combustible) glass particles that was compounded with PLLA to produce the 214 
composite membranes. Experiments were performed in platinum pans, at a heating rate 215 
of 40 kmin-1 from 50 to 700 °C in an oxygen atmosphere. 216 
2.4. In vitro culture of BM-MSCs on electrospun membranes 217 
2.4.1. Isolation and expansion of BM-MSCs 218 
Bone marrow mesenchymal stem cells (BM-MSCs) were isolated from bone marrow of 219 
4-5 week-old male Wistar rats according to the method established by Maniatopoulos et 220 
al. [34] and recently used by by Santocildes-Romero [31]. BM-MSCs were expanded in 221 
EDVDO PHGLXP FRQVLVWLQJ RI 'XOEHFFR¶V PRGLILHG (DJOH¶V PHGLXP '0(0 6LJPD-222 
Aldrich, UK), supplemented with 100 U/mL penicillin (Sigma-Aldrich, UK) and 100 223 
µg/mL streptomycin (Sigma-Aldrich, UK). Cells were cultured at 37 ºC in an 224 
atmosphere of 5 % CO2. 225 
2.4.2. Culture of BM-MSCs 226 
Prior to the in vitro studies, BM-MSCs, at passage 2, were harvested and seeded at a 227 
density of 3×104 cells per membrane of Ø = 6.5 mm held in plastic inserts 228 
&HOO&URZQ 24, Scaffdex, UK). Cells were cultured for 7, 14 and 21 days under static 229 
conditions. All scaffold conditions were cultured in basal and osteogenic differentiation 230 
media (basal medium supplemented with 50 µg/mL L-DVFRUELF DFLG  P0 ȕ-231 
glycerophosphate and 10-8 M dexamethasone). 232 
2.4.3. BM-MSCs proliferation, viability and morphology 233 
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Morphological evaluation of cultured cells: After each time-point the cells cultured 234 
on the membranes were washed with PBS and fixed with 4% formalin solution (0.5 mL) 235 
for 15 min at room temperature (RT). The cells were then washed with PBS, containing 236 
0.2 % Triton X, for 2 min. After the fixation and permeation steps, the cells were 237 
washed again with PBS and stained with 4,6-diamidino-2-phenyindole dilactate (1:1000 238 
DAPI, Sigma-Aldrich, UK) for 2 min at RT, and phalloidin-tetramethylrhodamine B 239 
isothiocyanate (Sigma-Aldrich, UK) for 1 h at RT. Finally, the cells were washed and 240 
observed using an Axioplan 2 imaging fluorescent microscope with a digital camera 241 
QIC AM 12-bit (Zeiss, UK). 242 
Cell viability and proliferation (PrestoBlue® and PicoGreen® assays). The 243 
PrestoBlue® reagent (Fisher Scientific, UK) is a resazurin-based solution that is reduced 244 
to resorufin by viable cells which can be detected flurometrically.  The cell viability 245 
DVVD\ ZDV H[HFXWHG DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV ,Q EULHI WKH246 
PrestoBlue® reagent was added to a final concentration of 10 % to the cell culture 247 
medium and the cultures incubated for 1 h at 37 oC. 200 µL samples of the culture 248 
medium were removed and placed in 96-well plates and the resorufin fluorescence 249 
quantified spectrophotometrically using a plate reader (Tecan Infinite M200). The 250 
fluorescence was determined at an excitation wavelength of 560 nm and emission 251 
wavelength of 590 nm. The metabolic activity was presented in fluorescence values and 252 
compared with the control (cell cultured onto PLLA membranes under basal medium 253 
conditions). 254 
The PicoGreen® dsDNA reagent (Invitrogen, USA) is an ultrasensitive fluorescent 255 
nucleic acid dye for quantification of double-stranded DNA (dsDNA) in solution. This 256 
assay enables measurement of cell proliferation. After each culturing period, the cells 257 
were washed with PBS and incubated at 37 ºC for 3 h followed by a freezing step at -80 258 
11 
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ºC for overnight in ultra-pure water (1 mL) to ensure the cell lysis. Finally, the 259 
fluorescence was determined at an excitation wavelength of 485 nm and emission 260 
wavelength of 528 nm. The DNA concentration was presented in µg/mL and compared 261 
with the control (cell cultured onto PLLA membranes under basal medium conditions). 262 
2.4.3. Alkaline phosphatase quantification 263 
The concentration of alkaline phosphatase (ALP) was determined for all the cell culture 264 
time points, using the lysates used for the DNA quantification and the Alkaline 265 
Phosphatase, Diethanolamine Detection kit (Sigma-Aldrich, UK), which is based on the 266 
conversion of p-nitrophenyl phosphate (pNPP) to free p-nitrophenol by ALP. In brief, a 267 
buffered pNPP solution was prepared and equilibrated at 37 ºC. Afterwards, 2 % (v/v) 268 
of sample or control lysate was added. Immediately after mixing the absorbance was 269 
UHDGDWQPLQDSODWHUHDGHU7HFDQ,QILQLWH0IRU§PLQ$Q$/3VWDQGDUG270 
solution was used as control and buffer as blank. The units were calculated according to 271 
the following Eq. (3): 272 
ሺ ?࡭૝૙૞࢔࢓Ȁ ܕܑܖ ࢀࢋ࢙࢚ି ?࡭૝૙૞࢔࢓Ȁ ܕܑܖ ࡮࢒ࢇ࢔࢑ሻൈࢊࢌൈࢂࡲ૚ૡǤ૞ൈࢂࡱ     Eq. (3) 273 
Where df = dilution factor; VF = Volume of final solution; 18.5 = millimolar extinction 274 
coefficient of pNPP at 405 nm and VE = Volume of samples/ALP standard solution. 275 
2.4.4. RNA isolation and real-time quantitative polymerase chain reaction (rtPCR) 276 
RNA was extracted with Tri-reagent (Sigma-Aldrich, UK) according to the 277 
manufacturer's instructions. The RNA concentration was determined by 278 
microspectrophotometry (NanoDrop 1000). The cDNA synthesis was performed using 279 
the qScript cDNA synthesis kit (Quanta BioSciences, VWR) with 100 ng of RNA 280 
template in a final volume of 20 ȝL. Cycling was as follows: 1 cycle at 22 °C, 5 min; 1 281 
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cycle at 42 °C, 30 min; 1 cycle at 85 °C, 5 min. The amplification of the target cDNA 282 
was performed using the PerfeCTa SYBR Green FastMix (Quanta BioSciences) with 1 283 
ȝ/RIF'1$Q0RIHDFKSULPHUTable 1) in a final volume of 20 ȝ/. Real time-284 
PCR cycling was as follows: 1 cycle at 95 °C, 2 min; 44 cycles at 95 °C; 10 s at gene 285 
annealing temperature (Table 1); 30 s at 72 °C; followed by dissociation curve analysis. 286 
All the reactions were carried out on a PCR cycler Mastercycler Realplex (Hamburg, 287 
Germany). The transcripts expression data were normalized to the housekeeping gene 288 
JO\FHUDOGHK\GH--SKRVSKDWHGHK\GURJHQDVH (Gapdh) in each sample. The quantification 289 
was performed according to the Livak method (2íǻǻ&W method [35]), considering as 290 
calibrator at each time point the PLLA - basal medium for PLLA- osteogenic medium 291 
and PLLA-BBG-Sr basal medium for PLLA-BBG-Sr osteogenic medium (threshold = 292 
1). 293 
Table 1. Primers used for qPCR 294 
Gene 3ULPHUVHTXHQFH¶-¶)RUZDUGUHYHUVH Tm 
(ºC) 
Osteocalcin (Bglap) CATCTATGGCACCACCGTTT 60.0 
  AGAGAGAGGGAACAGGGAGG  
Osteopontin (Spp1) ATCTCACCATTCCGATGAATCT 60.0 
 CAGTCCATAAGCCAAGCTATCA  
Osterix (Sp7) CACTGGCTCCTGGTTCTCTC 60.0 
 CCACTCCTCCTCTTCGTGAG  
Alkaline phosphatase (Alpl) TGCCTTACCAACTCATTTGTG 57.4 
 ACGCGATGCAACACCACTC  
 295 
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3. Results and discussion 296 
3.1. Characterisation of electrospun membranes 297 
The PLLA and PLLA-BBG-Sr (10 % w/w BBG-Sr/PLLA) composite membranes were 298 
successfully obtained by electrospinning. TGA analysis confirmed that we successfully 299 
incorporated 10 % (w/w) of BBG-Sr microparticles in the PLLA fibres. The 300 
morphology, microstructure and fibre integrity of the electrospun PLLA and PLLA-301 
BBG-Sr membranes was characterised by scanning electron microscopy (SEM) and 302 
µCT. Electrospun PLLA and PLLA-BBG-Sr membranes are composed of smooth and 303 
uniform fibres. No large particles were detected (Figure 1a and 1c), however, the 304 
formation of small agglomerates in the membranes containing the BBG-Sr 305 
microparticles was observed [36]. Figure 1c highlights in red circles the BBG-Sr 306 
microparticles incorporated into the fibres. The homogeneous distribution of the BBG-307 
Sr microparticles in the PLLA-BBG-Sr membrane could be observed in the 2D virtual 308 
model representatively obtained using an image processing software CTvox of µCT 309 
images (Figure 1d), in which the red colour represents the BBG-Sr microparticles 310 
distributed into the composite membranes in green. As expected, the PLLA membranes 311 
do not present any particles in their structure (Figure 1b). 312 
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Figure 1. SEM micrographs (a and c) and representative µCT 2D images (b and d) of 314 
PLLA and PLLA-BBG-Sr membranes. The areas encompassed by red lines in (c) show 315 
particles incorporated into the fibres. In (b and d) PLLA fibres are represented in green 316 
and the BBG-Sr microparticles are represented in red. 317 
The mechanical properties of the biomaterials are important in providing physical 318 
support for cell growth and migration matching those of the tissue at the site of 319 
implantation [37]. Figure 2a presents the stress±strain curves obtained for the PLLA 320 
and PLLA-BBG-Sr membranes under tensile load up to a strain of 50 %. The PLLA-321 
BBG-Sr membranes showed the highest tensile strength (0.75 ± 0.7 MPa), when 322 
compared to the PLLA membranes (0.55  ± 0.6MPa), indicating that the incorporation 323 
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of BBG-Sr reinforced the membranes. The same trend was observed for the <RXQJ¶V324 
modulus (Figure 2b), calculated from the initial linear slope of the stress-strain curves, 325 
where the loading of BBG-Sr microparticles improved the modulus from 14.6 ± 3.8 326 
MPa (PLLA) to 24.7 ± 5.3 MPa (PLLA-BBG-Sr). This might be due to an increase in 327 
rigidity through the filler effect, in which the microparticles encumber the movement of 328 
the polymer chains and the amount of extendable material in the membrane. On the 329 
other hand, while the incorporation of the microparticles in PLLA-BBG-Sr membranes 330 
can affect the tensile strength, where there is no interaction between fibres and particles. 331 
The availability of cations derived from the incorporated microparticles may contribute 332 
to the crosslinking of the carboxylic acid groups (that are present in the chain ends of 333 
the PLLA) through the formation of carboxylates with the cations released from the 334 
microparticles. These carboxylate cross-links induce the interlocking of the membranes, 335 
resulting in an improvement of the Young modulus [38] As demonstrated by Thomas et 336 
al. [39], small concentrations of nano hydroxyapatite (HA) resulted in a reinforcement 337 
of PCL. It was observed by Jeong et al. [40] in an analogous way that the addition of 338 
increasing concentrations of HA increasingly enhanced the mechanical properties of the 339 
composite, namely their tensile strength and <RXQJ¶VPRGXOXV. Therefore, our results 340 
support that, with the inclusion of BBG-Sr microparticles into the PLLA matrix, it is 341 
possible to tune their mechanical properties, contribution to be a closer match of those 342 
from the living tissue at the site of implantation. 343 
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 344 
Figure 2. (a) Stress±strain curves of PLLA and PLLA-BBG-Sr membranes and their 345 
respective (b) Young's modulus determined from the initial slope of the curves. The 346 
data was analysed by non-parametric statistics: Mann-Whitney test revealed a 347 
significance of p<0.05 (*). 348 
 349 
3.2. Degradation of the electrospun membranes 350 
A biomaterial suitable for promoting bone regeneration in a tissue engineering 351 
perspective should present an appropriate biodegradability. The BTE concept is based 352 
on the substitution of the biomaterial by new bone. This requires that the degradation 353 
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rate of the biomaterial matches that of new bone formation, in order to occur a 354 
progressive substitution of the biomaterial by the new bone tissue [15, 41]. The 355 
degradation profiles of PLLA and PLLA-BBG-Sr membranes (Figure 3) were 356 
evaluated from the weight loss and water uptake, as well as the release of chemical 357 
species from the membranes and pH of the immersion solutions. The water uptake and 358 
weight loss data showed differences between the PLLA and the PLLA-BBG-Sr 359 
membranes (Figure 3a and b). Both membranes presented steady and continuous water 360 
uptake and weight loss from week 2 to week 3. However, the PLLA-BBG-Sr 361 
PHPEUDQHVSUHVHQWHGDPRUHSURQRXQFHGµEXUVW¶RIZHLJKW ORss during the first week. 362 
The differences between the two membranes during this initial stage of degradation 363 
might be attributed to the penetration of the PBS solution through the polymer/glass 364 
interface and/or surface cracks that facilitated the degradation of the material and 365 
enhanced the water uptake. Another possibility is related with a superficial hydrolytic 366 
degradation generated by the leaching of chemical species from the glass particles [42, 367 
43]. The pH measurements presented no significant variation of pH for both PLLA and 368 
PLLA-BBG-Sr membranes over time. It was observed an increasing release of B, Si and 369 
Sr from the PLLA-BBG-Sr membranes over time of immersion (Figure 3c). The 370 
release of such chemical species can only be originated from the BBG-Sr 371 
microparticles, confirming that the weight loss is mainly caused by the hydrolytic 372 
degradation of the glass particles. During the last week of degradation (21 to 28 days) it 373 
was also noticed an increase in the PLLA-BBG-Sr weight loss that is in line with the 374 
reduction of glass content as determined by TGA tests (Figure 3d) and the increased 375 
concentration of mainly B and Sr-containing chemical species, that were leached from 376 
the glass particles to the immersion medium (detected by ICP). The increase on the 377 
degradation is clear during the last week; however, the leaching observed by ICP during 378 
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the first 3 weeks is not corroborated by the TGA analysis. In this case, the presence of 379 
phosphates from the solution buffer might generate a surface layer of strontium 380 
phosphate that limits the mass exchange from the glass particles to the immersion 381 
solution. In this case, the weight loss derived from the leaching of B, Si and Sr from the 382 
glass particles is partially compensated by the deposition of phosphates. The fact that 383 
the PLLA-BBG-Sr composite membranes lost twice the mass during the degradation 384 
process suggests that the incorporation of BBG-Sr into PLLA fibres increased the 385 
degradability and the degradation rate of the membranes, as well as the release of active 386 
chemical species to the surrounding medium [15]. 387 
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 388 
Figure 3. Degradation profile of the PLLA and PLLA-BBG-Sr membranes during 30 389 
day of degradation in PBS at 37 ºC. (a and d) WU and WL of the PLLA and PLLA-390 
BBG-Sr membranes; (c) release profiles of chemical species from the PLLA-BBG-Sr 391 
membranes; and (d) percentage of glass (w/w) in the studied membranes. 392 
 393 
3.3. In vitro biological evaluation 394 
Morphology, viability and proliferation of the BM-MSCs 395 
Apart from the suitable chemical and physical properties of the biomaterial, it is also 396 
crucial to evaluate if theyare cytotoxic.. To this purpose, direct contact assays are 397 
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widely used as a preliminary screening for biomaterials [44]. Fluorescence microscopy 398 
images (Figure 4a) show the morphology of BM-MSCs cultured in the presence of 399 
PLLA and PLLA-BBG-Sr membranes in basal or osteogenic medium (Figure 4a, Basal 400 
and Osteo, respectively). The attached BM-MSCs displayed a well-spread morphology 401 
and several cell-to-cell contacts. As expected, the PrestoBlue® and PicoGreen® data 402 
(Figure 4b and 4c) demonstrated that the cells proliferated over the time course under 403 
basal conditions, which is consistent with the morphology images (Figure 4a). There is 404 
also and increase on their metabolic activity (day 7 versus day 21). However, under 405 
osteogenic conditions BM-MSCs did not proliferate and exhibited an increase 406 
inmetabolic activity (day 7 versus day 21), which suggested the occurrence of 407 
differentiation [8, 45]. PLLA and PLLA-BBG-Sr electrospun membranes were found to 408 
be a non-cytotoxic support for BM-MSCs attachment and proliferation (Figure 4) 409 
without any adverse effect caused by the addition of BBG-Sr particles. Inaddition, the 410 
randomly distributed fibres and porous structure of electrospun membranes should 411 
enable an efficient transfer of nutrients, as well as support suitable cell penetration into 412 
the bulk of the membranes. 413 
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 414 
Figure 4. (a) Morphology, (b) metabolic activity and (c) proliferation of BM-MSCs 415 
cultured for 7, 14 and 21 days in basal (basal) or osteogenic medium (osteo), and in the 416 
presence of PLLA or PLLA-BBG-Sr. In the representative microscopy images (a) the 417 
nuclei of cells are stained in blue (DAPI) and the actin filaments are stained in green 418 
(Phalloidin). In Figure 4b and 4c, the results are expressed as means ± standard 419 
deviation with n = 3 for each experimental data point. The data were analysed by non-420 
parametric statistics: Kruskal-Wallis test IROORZHG E\ D 'XQQ¶V 0XOWLSOH &RPSDULVRQ421 
test and were marked as: *** p<0.001; **p<0.01; * p<0.05. On the graphs the ILJXUHµ1¶ 422 
represents the comparison with day 7 and WKHILJXUHµ2¶ represents the comparison with 423 
day 14. 424 
3.3. Osteogenic differentiation markers 425 
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It has been demonstrated that the release of chemical species containing Si, B or Sr from 426 
BBG-Sr glass particles could stimulate the osteoblast proliferation and differentiation. 427 
The ALP activity is commonly related with functional activity of the bone-derived cells, 428 
such as their osteogenic differentiation and the onset of mineralisation [36, 46]. In order 429 
to execute a preliminary evaluation on the capacity of the PLLA-BBG-Sr membranes to 430 
induce osteogenic differentiation, we cultured BM-MSCs onto them and quantified the 431 
ALP activity after 7, 14 and 21 days (Figure 5b). SEM was also used to check for 432 
mineral deposits and the mineralisation stage of the BM-MSCs (Figure 5a). In the SEM 433 
micrographs it is possible to confirm that the BM-MSCs create a cell layer attached to 434 
the PLLA and PLLA-BBG-Sr membranes. However, in the case of BM-MSCs cultured 435 
under osteogenic conditions, formation of phosphate deposits at the later time points 436 
(Figure 5a, day 21) were observed. In contrast, ALP activity (Figure 5b) increased 437 
during the time of culture under osteogenic conditions, suggesting that the addition of 438 
BBG-Sr microparticles increased the ALP expression levels. Therefore, the PLLA-439 
BBG-Sr membranes stimulated the BM-MSCs to initiate their osteogenic 440 
differentiation. This stimulus is very likely to be related with the presence of the B, Si 441 
and Sr chemical species leaching from the BBG-Sr glass particles to the surrounding 442 
medium [47, 48], as also shown in the ICP data (Figure 3a). Comparatively, some 443 
authors [31, 32] studied the effect of the release of Si and Sr chemical species from BG, 444 
and found that they stimulate cell differentiation. Other authors have also demonstrated 445 
improvements in cell differentiation and bone mineralisation by the addition of glass 446 
particles into polymeric matrices [6, 36, 49]. As an example, Santocildes-Romero [9], 447 
fabricated electrospun membranes incorporating 10% BGSr glass particles with 448 
increasing Sr composition with no cytotoxic effects on at osteosarcoma cells; Rajzer 449 
and co-workers [36] verified that the addition of 20% hydroxyapatite ceramic particles 450 
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into PLDL electrospun composites could direct HAp mineralisation in cell culture; Ren 451 
et al. [6] also showed that PCL-SrBG electrospun scaffolds enhanced the ALP activity 452 
of MC3T3-E1 cells in the presence of osteogenic media in comparison with the glass-453 
free PCL scaffolds after 21 days of culture. Hence, the addition of BBG-Sr glass 454 
particles to PLLA fibres accelerates the BM-MSCs osteogenic differentiation (ALP 455 
activity, Figure 5a), in the presence of osteogenic media after 14 days of cell culture, 456 
showing an higher increase after 21 days of cell culture. 457 
 458 
Figure 5. (a) Morphology/mineralisation (SEM micrographs) of BM-MSCs and their 459 
(b) ALP activity after 7, 14 and 21 days of culture in the presence of PLLA and PLLA-460 
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BBG-Sr, in basal (basal) or osteogenic medium (osteo). ALP results are expressed as 461 
mean ± standard deviation with n = 3 for each datapoint. The data was analysed by non-462 
parametric statistics: Kruskal-:DOOLV WHVW IROORZHG E\ D 'XQQ¶V 0XOWLSOH &RPSDULVRQ463 
test. ** (p<0.01); * (p<0.05). The significance is in relation to cells cultured on PLLA (in 464 
the absence of BBG-Sr glass particles) under the same culture conditions. 465 
 466 
Complementary to the reported viability, proliferation and ALP activity data, the 467 
differentiation level of BM-MSCs cultured onto PLLA and PLLA-BBG-Sr membranes 468 
was assessed by quantitative PCR of selected bone-specific gene transcripts. In the 469 
literature it is well described that osteogenic differentiation of BM-MSCs has three 470 
phases: the proliferative phase, which is followed by the ECM synthesis and maturation, 471 
and lastly the mineralisation phase [50, 51]. Therefore, in this study the osteogenic 472 
potential of the cells was evaluated at day 14 and 21 using the expression pattern of the 473 
representative osteogenic markers: Alpl, Spp1, Bglap and Sp7 [8, 52]. The transcripts 474 
expression data were normalized against the housekeeping gene Gapdh and the 475 
quantification performed according to the Livak method (2-ǻǻ&W method), considering 476 
the PLLA (basal medium) as calibrator for PLLA (osteogenic medium) and PLLA-477 
BBG-Sr (basal medium) as calibrator for PLLA-BBG-Sr (osteogenic medium). 478 
Commonly, Alpl acts as early marker of the osteoblastic phenotype. This gene 479 
expression level is known to increase with the progression of osteoblastic differentiation 480 
[53]. According to the gene expression data (Figure 6a) there is a significant up-481 
regulation of Alpl in the BM-MSCs cultured onto PLLA-BBG-Sr membranes at 14 and 482 
21 days of culture in relation to BM-MSCs cultured onto PLLA membranes (all under 483 
osteogenic medium). Again, the Ren et al. found the same Alpl gene up regulated in 484 
MC3T3 cells cultured in PCL-SrBG membranes, but only after 21 days of culture. 485 
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These observations are consistent with the quantification of the ALP activity (Figure 486 
5b), in which there was a significantly higher activity for the BM-MSCs cultured onto 487 
PLLA-BBG-Sr (under osteogenic medium) after 14 days of culture, when compared 488 
with the cells cultured onto PLLA [47, 48]. Regarding the maturation and 489 
mineralization phase, we investigated the expression of the genes that encode two non-490 
collagenous proteins present with the ECM of bone, e.g. Spp1 and Bglap. Spp1 is a 491 
protein found in bone, teeth, kidneys and epithelial lining tissue; consequently, Spp1 492 
cannot be considered bone-specific, although it is associated to bone related functions 493 
[8, 45]. The Spp1 gene expression results (Figure 6b) showed that at 14 days of culture, 494 
BM-MSCs cultured on PLLA presents a high Spp1 expression, which might be related 495 
with their important functions in cell adhesion, migration and survival [53]. The fact 496 
that Spp1 expression is significantly higher when cultured on PLLA membranes might 497 
be a result of proliferation and cell spreading processes. On the other hand, Bglap, 498 
which is the second most abundant protein present in bone, is exclusively secreted by 499 
osteoblastic cells at the last stage of maturation [45, 53]. When cultured on PLLA-BBG-500 
Sr membranes, Bglap expression (Figure 6c) is significantly higher in relation to the 501 
basal medium for 14 and 21 days of culture. This suggests that the combined effect of 502 
the osteogenic factors and the dissolution products might be enhancing Bglap gene 503 
expression, which may be an indicator of osteoblastic differentiation. This data is in 504 
accordance with the report of Strobel et al. [54] showing that BM-MSCs, after 14 days 505 
of exposure to cell culture medium containing nanoparticles of Sr-substituted Bioglass, 506 
increased their  Bglap expression. Finally, Sp7 is a well-characterised osteoblast specific 507 
gene and it is associated with the regulation of numerous other genes (e.g. osteocalcin, 508 
osteopontin, bone sialoprotein), and is acknowledged as a late bone marker that plays a 509 
key role in the differentiation of preosteoblasts into fully functioning osteoblasts [8, 53]. 510 
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Our data at day 21 registered an increase of Sp7 gene expression in the BM-MSCs 511 
cultured on PLLA-BBG-Sr membranes (under osteogenic medium) in relation to the 512 
same cells cultured on the same membranes but under basal medium, as well as the cells 513 
cultured onto PLLA (under osteogenic and basal medium). These observations are 514 
consistent with the overexpression of the other monitored gene Alpl and their protein 515 
expression (ALP) for PLLA-BBG-Sr membrane [55]. In fact, Isaac et al. [56] 516 
demonstrated that the addition of strontium to bioactive glass particles resulted in a 517 
significant up-regulation of Runx2 and Osterix of osteoblastic cells. In summary, the 518 
detected overexpression of Alpl, Bglap and Sp7 genes in cells cultured onto PLLA-519 
BBG-Sr membranes show that the incorporation of BBG-Sr glass particles into the 520 
PLLA membranes promotes the osteogenic differentiation of BM-MSCs [47]. 521 
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 522 
Figure 6. Relative gene expression profile of BM-MSCs cultured onto PLLA and 523 
PLLA-BBG-Sr membranes during 14 and 21 days. Selected genes: Alpl, osteogenic 524 
mineralisation initiators (a); Spp1 (b) and Bglap (c), extracellular matrix; Sp7, 525 
transcription factors. The transcripts¶ expression data were normalized against the 526 
housekeeping gene Gapdh and the quantification performed according to the Livak 527 
method (2-ǻǻ&W method). For each timepoint it was used: the calibrator PLLA (in basal 528 
medium) for the experiments with PLLA (in osteogenic medium); and the calibrator 529 
PLLA-BBG-Sr (in basal medium) for the experiments with PLLA-BBG-Sr (in 530 
osteogenic medium). In all the cases the calibrator is represented as a dashed line 531 
(threshold = 1). The results are expressed as mean ± standard deviation with n = 3 for 532 
each bar. The data was analysed by non-parametric statistics: Kruskal-Wallis test, 533 
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IROORZHG E\ D 'XQQ¶V 0XOWLSOH &RPSDULVRQ WHVW and differences were considered: *** 534 
p<0.001; ** p<0.01; and * p<0.05. D GHQRWHV VLJQLILFDQW GLIIHUHQFHV LQ UHODWLRQ WR FHOOV535 
FXOWXUHG LQEDVDOPHGLXP3//$RU3//$-%%*-6UEGHQRWHV VLJQLILFDQWGLIIHUHQFHV LQ536 
UHODWLRQWRFHOOFXOWXUHGRQWR3//$LQRVWHRJHQLFPHGLXP 537 
4. Conclusion 538 
Bioactive membranes of PLLA-BBG-Sr composites were successfully prepared using 539 
electrospinning. The µCT data evidenced that BBG-Sr microparticles were 540 
homogeneously incorporated into the fibres and the membrane structure. Our data 541 
indicated that, the addition of BBG-Sr into the PLLA matrix improved the in vitro water 542 
uptake and degradability of the membranes. Moreover, the incorporation of the BBG-Sr 543 
microparticles improved the mechanical properties of the membranes, namely in their 544 
Young modulus and tensile strength. The in vitro biological evaluation confirmed that 545 
both PLLA and PLLA-BBG-Sr membranes are able to promote the attachment of BM-546 
MSCs, without any cytotoxic effects. Furthermore, the addition of BBG-Sr 547 
microparticles to the PLLA membranes increased the ALP activity (under osteogenic 548 
conditions), as well as the BM-MSCs osteogenic differentiation as shown by up-549 
regulation of Alpl, Sp7 and Bglap gene expression in vitro. The present work suggests 550 
that the composite of PLLA membranes and BBG-Sr microparticles can be used as a 551 
strategy to prepare bioactive composite membranes for bone regeneration. 552 
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